Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$244M |
| 2 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$143M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$137M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$109M |
| 5 |
VMW
VMware, Inc
VMW
|
+$103M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.2B |
| 2 |
Apple
AAPL
|
+$763M |
| 3 |
Microsoft
MSFT
|
+$618M |
| 4 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$592M |
| 5 |
AABA
Altaba Inc
AABA
|
+$393M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.41% |
| 2 | Healthcare | 5.88% |
| 3 | Financials | 5.51% |
| 4 | Consumer Discretionary | 4.79% |
| 5 | Communication Services | 4.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KYNB
4201
Kyntra Bio
KYNB
$29.4M
| $342K | ﹤0.01% |
219
-773
| -78% | -$1.01M |
|
4202
Photronics
PLAB
$1.93B
| $342K | ﹤0.01% |
42,920
+1,851
| +5% | +$15.3K |
|
4203
QuinStreet
QNST
$1.21B
| $342K | ﹤0.01% |
26,934
+12,620
| +88% | +$159K |
|
|
SFIX
4204
Stitch Fix
SFIX
$560M
| $342K | ﹤0.01% |
12,442
-103,061
| -89% | -$2.33M |
|
4205
PUT
Direxion Daily 20+ Year Treasury Bull 3X ETF
TMF
$2.17B
| $341K | ﹤0.01% |
1,760
+950
| +117% | +$176K |
|
|
RVNC
4206
DELISTED
Revance Therapeutics, Inc.
RVNC
| $341K | ﹤0.01% |
12,410
-13,540
| -52% | -$407K |
|
4207
PUT
Live Nation Entertainment
LYV
$42.1B
| $340K | ﹤0.01% |
7,000
-3,000
| -30% | -$128K |
|
|
AKCA
4208
DELISTED
Akcea Therapeutics Inc
AKCA
| $340K | ﹤0.01% |
14,365
+3,053
| +27% | +$72.9K |
|
|
GMS
4209
DELISTED
GMS Inc
GMS
| $339K | ﹤0.01% |
12,497
+3,365
| +37% | +$102K |
|
|
GTY
4210
Getty Realty Corp
GTY
$2.07B
| $339K | ﹤0.01% |
12,037
-696
| -5% | -$18K |
|
4211
CALL
IQVIA
IQV
$39.3B
| $339K | ﹤0.01% |
3,400
+1,600
| +89% | +$160K |
|
4212
Laureate Education
LAUR
$5.28B
| $338K | ﹤0.01% |
23,612
+10,522
| +80% | +$155K |
|
|
HMHC
4213
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $338K | ﹤0.01% |
44,170
+22,709
| +106% | +$161K |
|
4214
CALL
Factset
FDS
$10.2B
| $337K | ﹤0.01% |
1,700
-1,700
| -50% | -$340K |
|
4215
Halozyme
HALO
$12.2B
| $337K | ﹤0.01% |
20,036
-34,889
| -64% | -$660K |
|
4216
KRONOS Worldwide
KRO
$989M
| $335K | ﹤0.01% |
14,881
-1,309
| -8% | -$31.2K |
|
4217
PUT
LKQ Corp
LKQ
$6.29B
| $335K | ﹤0.01% |
10,500
+10,300
| +5,150% | +$344K |
|
4218
PUT
MPLX
MPLX
$59.7B
| $335K | ﹤0.01% |
9,800
-6,600
| -40% | -$230K |
|
|
SBBP
4219
DELISTED
Strongbridge Biopharma plc.
SBBP
| $335K | ﹤0.01% |
55,771
+34,662
| +164% | +$254K |
|
4220
Fulton Financial
FULT
$4.64B
| $334K | ﹤0.01% |
20,212
-18,051
| -47% | -$313K |
|
|
OSG
4221
Octave Specialty Group
OSG
$222M
| $333K | ﹤0.01% |
16,760
+5,921
| +55% | +$109K |
|
4222
Camping World
CWH
$653M
| $333K | ﹤0.01% |
13,345
-8,956
| -40% | -$223K |
|
4223
ProShares UltraShort Bloomberg Crude Oil
SCO
$728M
| $333K | ﹤0.01% |
279
+45
| +19% | +$64.3K |
|
|
MRNS
4224
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $333K | ﹤0.01% |
11,764
-3,361
| -22% | -$74.5K |
|
|
SIOX
4225
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $332K | ﹤0.01% |
18,345
+9,692
| +112% | +$143K |
|
Similar funds
Barclays's Q2 2018 Portfolio in Review
As of Q2 2018, Barclays held 7,691 positions worth $116B, down 11% from $131B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Barclays withdrew a net $18.4B in Q2 2018, closing 585 positions and reducing 3,613 holdings. Its most notable exit was Time Warner Inc, an estimated $290M position sold in full.
By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 8.6% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in Evergy worth $42M.
- Barclays's largest Q2 2018 buy was Evergy: 747,502 shares worth $42M.
- Barclays added most to State Street Industrial Select Sector SPDR ETF in Q2 2018, an estimated $244M increase.
- Barclays's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.2B.
- Barclays fully exited Time Warner Inc in Q2 2018, selling an estimated $290M.
- Barclays's ten largest holdings make up 27% of its $116B portfolio in Q2 2018.
- Barclays opened 402 new positions and closed 585 in Q2 2018.
- Barclays's portfolio value fell 11% quarter-over-quarter to $116B.
Based on Barclays's 13F filing for Q2 2018, filed 14 Aug 2018.